Delivery Order SPE2DE21D7020-SPE2D625F0HTU
- Not listed
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for WALLSTENTS, with a fixed-price contract containing economic price adjustment provisions. The contract, valued at $10,455.54, is scheduled for completion by September 11, 2025, and represents a non-set-aside award. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures advanced cardiovascular and interventional medical...
- Boston Scientific Corp has been awarded a delivery order valued at $22,480.61 for wallstents under a Defense Health Agency Medical Supply Chain contract. The award, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. Performance will take place at the company's Marlborough,...
- This is a $4,404.40 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the provision of WALLSTENTS, which are likely medical stents used in various surgical procedures. The award has no set-aside designation and is associated with a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle. Boston Scientific is a for-profit organization and manufacturer that has received...
- The Defense Logistics Agency Troop Support Medical awarded a $3,302.64 fixed-price with economic price adjustment delivery order contract to Boston Scientific Corporation for WALLSTENTS. As the prime contractor, Boston Scientific will deliver the medical devices from its facility in Marlborough, Massachusetts under the terms of the one-week contract ending July 3, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency supports Department of Defense...
- Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $7,146.74 fixed price with economic price adjustment delivery order from the Defense Logistics Agency Troop Support Medical to provide WALLSTENTS. The place of performance is Marlborough, Massachusetts. No set-aside designation was indicated. Boston Scientific is a manufacturer of medical devices that provides implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices,...
- Boston Scientific Corp was awarded a delivery order valued at $4,351.60 for a drug-eluting vascular stent (7mm x 100mm x 130cm) on December 12, 2025, with an ultimate completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, Massachusetts. The award was made without a small business set-aside, allowing Boston Scientific to compete on an...
- This federal contract award to Boston Scientific Corp (doing business as Boston Scientific) was issued by the Defense Logistics Agency (DLA) for the supply of WALLFLEX TH STENTS, a medical device product. The contract has a ceiling value of $3,707.34 and is a Delivery Order under an Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of June 5, 2024. This award is not associated with...
- The Defense Logistics Agency Troop Support Medical awarded a $2,002 delivery order to Boston Scientific Corporation for WALLSTENTS under contract number 4561799365. As the prime contractor, Boston Scientific will provide medical devices from its Marlborough, Massachusetts location to fulfill the agency's requirements. The fixed price with economic price adjustment contract runs from August 14-21, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency...
- Boston Scientific Corp was awarded a delivery order valued at $3,326.30 by the Defense Health Agency's Medical Supply Chain for enroute TCAR stents, with performance in Marlborough, MA. The contract was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, and utilizes fixed-price pricing with economic price adjustment. This is an open competition award with no set-aside designation, allowing Boston Scientific to compete directly against other qualified vendors in...
- The Defense Logistics Agency Troop Support Medical awarded Boston Scientific Corporation a $3,634.59 delivery order contract to provide WALLFLEX TH STENTS. As the prime contractor, Boston Scientific will deliver the stents from its facility in Marlborough, Massachusetts. The fixed price with economic price adjustment contract runs from July 20, 2023 through August 2, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0HTUDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $8,699.73 for WALLSTENTS by the Defense Health Agency's Medical Supply Chain, a defense-focused federal entity responsible for supplying medical devices to the Department of Defense healthcare system. The contract, issued on August 6, 2025, with an ultimate completion date of August 13, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. Performance will be conducted at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a continuation of the company's established role as a critical supplier of specialized cardiovascular medical devices to federal healthcare agencies. As a global medical technology leader, Boston Scientific has demonstrated substantial capability in providing advanced medical devices to federal healthcare systems, including the Department of Veterans Affairs and Defense Health Agency through multiple indefinite delivery vehicles and blanket purchase agreements. This award reflects the company's ongoing responsibility to supply wallstents—specialized endovascular devices used in interventional procedures—to support federal healthcare operations. The contract was awarded without a set-aside designation, indicating open competition in the federal marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 8/6/25 |